{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-008754","form_type":"8-K","ticker":null,"cik":"0001892480","company_name":"Hempacco Co., Inc.","filed_at":"2023-11-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.320324+00:00","generated_at":"2026-06-07T22:23:01.115373+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Hempacco receives Nasdaq notice of non-compliance with audit committee requirement","bullets":["Nasdaq notified Hempacco on Nov 15, 2023 of non-compliance with Listing Rule 5605.","Non-compliance triggered by Oct 26, 2023 resignation of director Dr. Stuart Titus.","Cure period extends to next annual meeting or Oct 26, 2024 (or Apr 23, 2024 if earlier).","Company has identified two prospective independent directors to fill audit committee vacancies.","Non-compliance does not result in immediate delisting; company expects to cure within period."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-008754","json":"https://secwatch.observer/filing/0001477932-23-008754.json","markdown":"https://secwatch.observer/filing/0001477932-23-008754.md","text":"https://secwatch.observer/filing/0001477932-23-008754.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1892480/000147793223008754/0001477932-23-008754-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1892480/000147793223008754/hpco_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T22:23:01.115373+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e2e98ddaeef2314f77a2240a3c0fd652b43dff3a","claim":"Hempacco Co., Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605).","evidence_excerpt":"November 15, 2023, Hempacco Co., Inc. (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that the Company is not in compliance with Nasdaq’s audit committee requirements as set forth in Listing Rule 5605 (the “ Audit Committee Requirement ”). The Notice does not result in the immediate delisting of the Company’s common stock from The Nasdaq Capital Market. The Nasdaq listing rules require the Company to have an audit committee comprised of at least three independent directors, and as of Octo","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1892480/000147793223008754/0001477932-23-008754-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"audit committee"},{"label":"Rules","value":"5605"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}